Detalhe da pesquisa
1.
Complex karyotypes and KRAS and POT1 mutations impact outcome in CLL after chlorambucil-based chemotherapy or chemoimmunotherapy.
Blood
; 128(3): 395-404, 2016 07 21.
Artigo
Inglês
| MEDLINE | ID: mdl-27226433
2.
Long-term remissions after FCR chemoimmunotherapy in previously untreated patients with CLL: updated results of the CLL8 trial.
Blood
; 127(2): 208-15, 2016 Jan 14.
Artigo
Inglês
| MEDLINE | ID: mdl-26486789
3.
Venetoclax plus rituximab or obinutuzumab after allogeneic hematopoietic stem cell transplantation in chronic lymphocytic leukemia.
Haematologica
; 104(5): e224-e226, 2019 05.
Artigo
Inglês
| MEDLINE | ID: mdl-30792201
4.
Evaluation of a Prognostic Epigenetic Classification System in Chronic Lymphocytic Leukemia Patients.
Biomark Insights
; 17: 11772719211067972, 2022.
Artigo
Inglês
| MEDLINE | ID: mdl-35095271
5.
A Novel Recombinant Anti-CD22 Immunokinase Delivers Proapoptotic Activity of Death-Associated Protein Kinase (DAPK) and Mediates Cytotoxicity in Neoplastic B Cells.
Mol Cancer Ther
; 15(5): 971-84, 2016 05.
Artigo
Inglês
| MEDLINE | ID: mdl-26826117
6.
Comprehensive Analysis of Disease-Related Genes in Chronic Lymphocytic Leukemia by Multiplex PCR-Based Next Generation Sequencing.
PLoS One
; 10(6): e0129544, 2015.
Artigo
Inglês
| MEDLINE | ID: mdl-26053404